NASDAQ:NVCT | Cash Flow Statement | Nuvectis Pharma, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$7.02M
2026-03-31-$6.05M-$6.51M$0.00$7,000.00
2025-12-31-$7.31M-$3.97M$166,000.00
2025-09-30-$7.46M
2025-06-30-$6.33M
2025-03-31-$5.33M-$4.17M$0.00$15.51M
2024-12-31-$6.25M-$2.47M$3.83M
2024-09-30-$4.15M
2024-06-30-$4.43M
2024-03-31-$4.17M-$4.36M$0.00$4.7M
2023-12-31-$6.62M-$3.85M$917,000.00
2023-09-30-$5.88M
2023-06-30-$5.71M
2023-03-31-$4.05M-$4.78M$252,000.00
2022-12-31-$6.7M-$3.52M-$131,000.00
2022-09-30-$5.88M
2022-06-30-$3.57M
2022-03-31-$2.94M-$3.08M$14.03M
2021-12-31-$2.26M-$1.07M$0.00
2021-09-30-$4.67M
2021-06-30-$5.94M
2021-03-31-$23,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$26.44M-$16.01M$29.11M
2024-12-31-$19M-$12.25M$0.00$11.65M
2023-12-31-$22.26M-$15.95M$0.00$15.09M
2022-12-31-$19.09M-$13.56M$0.00$27.81M
2021-12-31-$12.89M-$9.5M$15.25M